Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Sep 11, 2022 8:04pm
233 Views
Post# 34955555

RE:RE:RE:Will BTI over take RVX in share price???

RE:RE:RE:Will BTI over take RVX in share price???,,Hummm,,,,, I certainly wouldnt count RVX as being the faster to market proposition in any shape or form. History supports this point. My gut feeling is that a small win by BTI in the clinic will out pace anything RVX has in its pipeline,,,even the 208 Phase lll data. My $$$ are on a partner making the move which solidifies our science in its place in reserch history! ,,I feel its coming and its going to come fast when it does. A few small verifications along the way will trigger share price appreciation in a big way,,,Just an opinion, but the possiblity in my mind is more realistic than anything we can expect from this inactive and disrespectful RVX management team. The time line for RVX is something like dark matter to us shareholders,,,as only DMcC, the promoter tells us he understands it,,,,lmao!,,,The time line for BTI is being squeezed,,havent you noticed!!,,,,that squeeze will hopefullychange the long term expectations into shortly down the road possibilities!,,life is a gamble and so is the market!,,again,,havent you noticed!
<< Previous
Bullboard Posts
Next >>